EPISODE · Apr 26, 2026 · 11 MIN
胰高血糖素样肽-1受体激动剂（GLP-1RA）在肝硬化领域的应用前景
from 消化肝病前沿资讯
本期播客聚焦胰高血糖素样肽-1受体激动剂（GLP-1RA）在肝硬化领域的应用前景。从最初用于糖尿病、肥胖，到ESSENCE等里程碑研究展现其在代谢功能障碍相关脂肪性肝炎中的逆转潜力，再到用药时机对疗效的关键影响，以及已硬化肝脏的效果局限与风险权衡。还探讨合并肝病、肌少症等副作用管理，并展望其对成瘾行为的潜在作用，为听众呈现全面认知。00:06GLP-1RA跨界肝病引关注00:52早期用药显著降低肝硬化风险01:49对已硬化者益处仍存疑02:55合并MASLD或具辅助作用03:52无法逆转但可防肝硬化恶化04:43死亡风险降幅依赖用药时机05:37肌少症成肝硬化用药隐忧06:30个体化策略平衡疗效风险07:18胆胰副作用风险需警惕08:19早期有效或因结构未严重09:08除减重或另有护肝机制10:07或具调节食欲助戒酒潜力
Embed this episode
Ready to play
胰高血糖素样肽-1受体激动剂（GLP-1RA）在肝硬化领域的应用前景
0:00
11:11
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of 消化肝病前沿资讯?
This episode is 11 minutes long.
When was this 消化肝病前沿资讯 episode published?
This episode was published on April 26, 2026.
Can I download this 消化肝病前沿资讯 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!